Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy And Safety of SAR236553/REGN727 Over 24 Weeks in Patients With Hypercholesterolemia

NCT01644474 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01644474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01644474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy And Safety of SAR236553/REGN727 Over 24 Weeks in Patients With Hypercholesterolemia
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2012
Completion date
July 31, 2013
Enrollment
103 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hypercholesterolemia